Adam Zimilover

Adam Zimilover

Auto-generated profile, based on publicly available information

Adam Zimilover

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell , Forest Hills, New York

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
AZAdam Zimilover
Adam Zimilover
IHIsaac Huml
Isaac Huml
Haemophagocytic lymphohistiocytosis (HLH) is an aggressive hyperinflammatory haematological condition often associated with malignancy, infection or rheumatological disorders. HLH has rarely been associated with medications, including antibiotics. We describe a case of a patient without significant medical history who presented with HLH following treatment with trimethoprim/sulfamethoxazole (TMP/SMX). Additionally, we will discuss the possible mechanism of medication-induced HLH as well as the successful use of dexamethasone as the sole treatment. Early diagnosis and treatment of this disease is critical and medication-induced HLH should be considered in cases without a clear aetiology. To our knowledge, this is the first case report of TMP/SMX-induced HLH that was successfully treated with steroid monotherapy and just the second case report of TMP/SMX-induced HLH.

5 August 2023 in American Journal of Infection Control
Verified
Journal Article
Closed access
KCKai-Ming Chang
Kai-Ming Chang
AHAya Haghamad
Aya Haghamad
PSPatricia Saunders-Hao
Patricia Saunders-Hao
ASAlexander Shaffer
Alexander Shaffer
NMNiloofar Mirsaidi
Niloofar Mirsaidi
PGPranisha Gautam-Goyal
Pranisha Gautam-Goyal

21 February 2023 in Infectious Diseases in Clinical Practice
Verified
Journal Article
Closed access
AZAdam Zimilover
Adam Zimilover
TWTaylor Do Wang
Taylor Do Wang
ASAcacia Ba Sheppard
Acacia Ba Sheppard
CHCarly I. Hirschberg
Carly I. Hirschberg
MEMarcia Epstein
Marcia Epstein
Aeromonas species can be the source of severe infections in immunocompromised individuals. We present a case of a 35-year-old pregnant patient who developed postpartum septic shock and acute decompensated heart failure in the setting of Aeromonas hydrophilia peritonitis and bacteremia. Her severe presentation was thought to have occurred secondary to underlying liver dysfunction and preeclampsia. We additionally discuss the common presentations and sources of Aeromonas infections along with risk factors for severe systemic disease.

27 November 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
VMValli Mani
Valli Mani
AZAdam Zimilover
Adam Zimilover
JHJI-CHENG HSIEH
JI-CHENG HSIEH
MGMaham Ghani
Maham Ghani
SKSimon Kashfi
Simon Kashfi
HDHenry Donaghy
Henry Donaghy
Cryptococcosis is a fungal infection that can cause pulmonary, central nervous system, or disseminated disease in immunosuppressed individuals. Although pulmonary cryptococcosis is known to rarely affect immunocompetent patients, there is limited research comparing the incidence and clinical outcomes of cryptococcosis in immunocompetent versus immunocompromised patients. A retrospective analysis was performed on patients with confirmed positive CSF PCR, CSF antigen, or serum cryptococcal antigen tests from 8 hospitals in New York from 2017-2022. Patients were classified as immunocompromised if they had HIV, an organ transplant, active cancer, or were on immunosuppressive medications at the time of diagnosis. Baseline demographic information, comorbidities, and clinical outcomes were recorded. Statistical methods performed include t-test, Chi-square, and Fisher exact test. 37 cases were identified with 9 cases (24%) in immunocompetent patients. There were no significant differences in age (p=0.82), gender (p=0.61), or BMI (p=0.15) amongst immunocompetent vs immunocompromised patients. Immunocompetent patients were more likely to have diabetes compared to immunocompromised patients (44% vs 21%, p = 0.04). Immunocompetent patients presented with meningitis more frequently (78% vs 41%, p = 0.05) with decreased mortality (11% vs 18%, p = 0.04) and no significant differences in rates of fungemia (21% vs 22%, p = 0.28). The majority of immunocompetent patients were treated inpatient and discharged on fluconazole without documented relapsed infection (77%). When assessing patients before and after 3/30/2020, the midpoint of our data timeline and beginning of the COVID pandemic, the proportion of immunocompetent cases increased (12% vs 35%, p = 0.03) while the total number of cases was relatively unchanged. Meningitis was a more common presentation than pulmonary disease in immunocompetent patients. Immunocompetent patients also had better outcomes with decreased mortality. Overall, the number of immunocompetent patients increased over the study period. Additional information about cryptococcosis in immunocompetent patients, as well as the role of diabetes and COVID infection as potential risk factors, warrants further study. All Authors: No reported disclosures